Radwa Marawan Abdel Halim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Radwa Marawan Abdel Halim has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Aly Mones
Department of Tropical Medicine, Ain Shams University, Cairo, Egypt
1 shared publicationAntoine Fekhry Abdel Massih
Department of Pediatrics and Neonatology, Faculty of Medicine, Cairo University, Giza, Egypt
1 shared publication- Cristiano Rizzo
Division of Metabolic Diseases and Hepatology, Ospedale Pediatrico Bambino Gesù IRCCS, 00165 Rome, Italy
1 shared publication Dalia Mossalam
Department of Pediatrics and Neonatology, Faculty of Medicine, Cairo University, Giza, Egypt
1 shared publication- Eman AlHussain A. Gawad
Clinical Pathology Department, Clinical and Chemical Pathology, Cairo University, Cairo 11796, Egypt
1 shared publication Emmanuel Fares
Department of Cardiology, Cairo University, Cairo, Egypt
1 shared publication
Latest Publications
- 28 July 2026
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 30 (9) , 233-240
The Expression Profile of microRNA Genes and NT-proBNP as Possible Predictors of One-Year Mortality in Egyptian Adults with Acute Heart Failure: A Prospective Biomarker Study
Background: Acute heart failure (AHF) is a prevalent and life-threatening condition that is associated with high morbidity and mortality, particularly in adults. MicroRNAs (miRNAs) have been identified as potential biomarkers in various cardiovascular diseases. Specifically, miR-302b-3p and miR-103 have demonstrated potential as biomarkers in heart failure. Objectives: This study aims to investigate the diagnostic and prognostic potential of circulating miR-302b-3p and miR-103 in AHF among Egyptian adults and the association between these miRNAs and NT-proBNP levels. Methods: The study involved 95 participants, comprising 45 Egyptian adults diagnosed with AHF and 50 age- and gender-matched healthy controls. Circulating levels of miR-302b-3p and miR-103 were measured using qRT-PCR, while NT-ProBNP levels were determined via enzyme-linked immunosorbent assay. Results: The expression of miR-302b-3p was significantly decreased in patients with AHF compared with healthy controls ( p < 0.05). The levels of this miRNA showed a significant negative correlation with NT-proBNP levels ( r = 0.78, p = 0.013). Lower levels of miR-302b-3p and increased NT-ProBNP levels correlated with more severe prognosis, including higher rates of hospitalization and 1-year mortality in patients with AHF ( p < 0.05). Conclusion: NT-ProBNP and miR-302b-3p serve as a promising biomarker for the diagnosis and prognosis of AHF in Egyptian adults that can further guide health care professionals for risk stratification and therapeutic response.
- 28 July 2026
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 30 (9) , 233-240
The Expression Profile of microRNA Genes and NT-proBNP as Possible Predictors of One-Year Mortality in Egyptian Adults with Acute Heart Failure: A Prospective Biomarker Study
Background: Acute heart failure (AHF) is a prevalent and life-threatening condition that is associated with high morbidity and mortality, particularly in adults. MicroRNAs (miRNAs) have been identified as potential biomarkers in various cardiovascular diseases. Specifically, miR-302b-3p and miR-103 have demonstrated potential as biomarkers in heart failure. Objectives: This study aims to investigate the diagnostic and prognostic potential of circulating miR-302b-3p and miR-103 in AHF among Egyptian adults and the association between these miRNAs and NT-proBNP levels. Methods: The study involved 95 participants, comprising 45 Egyptian adults diagnosed with AHF and 50 age- and gender-matched healthy controls. Circulating levels of miR-302b-3p and miR-103 were measured using qRT-PCR, while NT-ProBNP levels were determined via enzyme-linked immunosorbent assay. Results: The expression of miR-302b-3p was significantly decreased in patients with AHF compared with healthy controls ( p < 0.05). The levels of this miRNA showed a significant negative correlation with NT-proBNP levels ( r = 0.78, p = 0.013). Lower levels of miR-302b-3p and increased NT-ProBNP levels correlated with more severe prognosis, including higher rates of hospitalization and 1-year mortality in patients with AHF ( p < 0.05). Conclusion: NT-ProBNP and miR-302b-3p serve as a promising biomarker for the diagnosis and prognosis of AHF in Egyptian adults that can further guide health care professionals for risk stratification and therapeutic response.
- Open Access
- 3 September 2025
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 38 (9) , 2961-2968
Osteocalcin as a predictor of bone fracture in children with chronic kidney diseases
Background: The associations between biochemical indicators of osteocalcin and bone health are fairly well established in adults through observational studies. In this context, our objective was to assess serum level of uncarboxylated osteocalcin (uOC) and its relation to the incidence of bone fractures other bone health indices in children with CKD. Methods: We enrolled 102 patients classified into two groups: group A: CKD without KRT; group B: CKD on regular HD. The patients were followed throughout the study period. The study’s endpoint was either the occurrence of a bone fracture or the conclusion of the study period. Another 22 healthy individuals were involved as a control group. We measured uOC and various indicators of bone health including bone-specific alkaline phosphatase (BAP) on the same day of the fracture or at the end of the study period. Results: uOC was found significantly higher in CKD children in comparison to the control group ( p p = 0.047). In patients with fractures, uOC and BAP were significantly higher compared with patients without fractures ( p < 0.001 and 0.019, respectively). By logistic regression analysis, uOC was the only predictor of bone fractures ( p = 0.027, OR = 1.011). Conclusion: Elevated uOC levels were observed in children with CKD who experienced fractures, and these levels showed a correlation with BAP. Furthermore, uOC appears to be a reliable indicator of bone fractures in this population. Graphical
- 3 September 2025
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 38 (9) , 2961-2968
Open AccessOsteocalcin as a predictor of bone fracture in children with chronic kidney diseases
Background: The associations between biochemical indicators of osteocalcin and bone health are fairly well established in adults through observational studies. In this context, our objective was to assess serum level of uncarboxylated osteocalcin (uOC) and its relation to the incidence of bone fractures other bone health indices in children with CKD. Methods: We enrolled 102 patients classified into two groups: group A: CKD without KRT; group B: CKD on regular HD. The patients were followed throughout the study period. The study’s endpoint was either the occurrence of a bone fracture or the conclusion of the study period. Another 22 healthy individuals were involved as a control group. We measured uOC and various indicators of bone health including bone-specific alkaline phosphatase (BAP) on the same day of the fracture or at the end of the study period. Results: uOC was found significantly higher in CKD children in comparison to the control group ( p p = 0.047). In patients with fractures, uOC and BAP were significantly higher compared with patients without fractures ( p < 0.001 and 0.019, respectively). By logistic regression analysis, uOC was the only predictor of bone fractures ( p = 0.027, OR = 1.011). Conclusion: Elevated uOC levels were observed in children with CKD who experienced fractures, and these levels showed a correlation with BAP. Furthermore, uOC appears to be a reliable indicator of bone fractures in this population. Graphical
- 3 November 2024
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 17 (6) , 821-828
Association of cytochrome P450 CYP2C9 (rs1057910) gene polymorphism and ibuprofen response in preterm neonates diagnosed with patent ductus arteriosus
Background: Patent ductus arteriosus (PDA) closure is one of the most significant changes necessary to transition to extrauterine life. The failure of closure in preterm infants has been associated with a variety of complications. Aim and objectives: This study aim to investigate the correlation between cytochrome P450 CYP2C9 gene polymorphism and the response to ibuprofen treatment in preterm neonates with PDA. Subjects and methods: This prospective study was conducted on 64 preterm neonates with patent ductus arteriosus (hsPDA). The neonates were treated with ibuprofen and diagnosed using clinical and echocardiographic examinations. The study was carried out at the Neonatal Intensive Care Unit (NICU), Pediatric Department, Kasr Alainy and ElMounira Pediatric Hospitals, Cairo University, in June 2018. Results: A statistically significant difference in respiratory rate was observed between both groups ( p = 0.047). Additionally, there was a significant difference in the duration of treatment with ibuprofen ( p = 0.021). Treatment with ibuprofen had no impact on renal function parameters. The platelet count decreased after treatment with no statistical difference. Conclusion: Use of Oral ibuprofen is a highly effective treatment for HsPDA in preterm neonates, demonstrating a remarkable success rate of 92.2% and fewer adverse effects. Whilst no correlation between the CYP2C9 (rs1057910) gene polymorphism and the efficacy of oral ibuprofen response, Other factors affecting the response of oral ibuprofen and subsequent PDA closure include gestational age, birth weight, Apgar score at 5 min, ductal diameter, RDS, and sepsis.
- 3 November 2024
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 17 (6) , 821-828
Association of cytochrome P450 CYP2C9 (rs1057910) gene polymorphism and ibuprofen response in preterm neonates diagnosed with patent ductus arteriosus
Background: Patent ductus arteriosus (PDA) closure is one of the most significant changes necessary to transition to extrauterine life. The failure of closure in preterm infants has been associated with a variety of complications. Aim and objectives: This study aim to investigate the correlation between cytochrome P450 CYP2C9 gene polymorphism and the response to ibuprofen treatment in preterm neonates with PDA. Subjects and methods: This prospective study was conducted on 64 preterm neonates with patent ductus arteriosus (hsPDA). The neonates were treated with ibuprofen and diagnosed using clinical and echocardiographic examinations. The study was carried out at the Neonatal Intensive Care Unit (NICU), Pediatric Department, Kasr Alainy and ElMounira Pediatric Hospitals, Cairo University, in June 2018. Results: A statistically significant difference in respiratory rate was observed between both groups ( p = 0.047). Additionally, there was a significant difference in the duration of treatment with ibuprofen ( p = 0.021). Treatment with ibuprofen had no impact on renal function parameters. The platelet count decreased after treatment with no statistical difference. Conclusion: Use of Oral ibuprofen is a highly effective treatment for HsPDA in preterm neonates, demonstrating a remarkable success rate of 92.2% and fewer adverse effects. Whilst no correlation between the CYP2C9 (rs1057910) gene polymorphism and the efficacy of oral ibuprofen response, Other factors affecting the response of oral ibuprofen and subsequent PDA closure include gestational age, birth weight, Apgar score at 5 min, ductal diameter, RDS, and sepsis.
- Open Access
- 14 February 2023
- Published by Taylor & Francis in Egyptian Journal of Anaesthesia
- Vol. 39 (1) , 157-166
Precision medicine as a predictive factor for risk of hospitalization of recurrent ischemic stroke patients treated with low dose aspirin. A pilot study
Recurrent ischemic stroke risk after transient ischemic attack was underestimated by most of epidemiological studies due to the widespread use of very different and sometimes restrictive definitions for recurrent stroke instead of a standard definition, making it difficult to assess the benefit of early prevention of recurrence. Knowing that early intervention by treatment with aspirin reduced fatal recurrent stroke and proved to be cost effective by reducing hospital admission, it was worthwhile studying the pharmacogenetics association as well as biological risk factors of aspirin intolerance for patients with recurrent ischemic stroke. Accordingly, our primary outcome was to investigate the association of CYP2C9*3 (Rs1057910) polymorphism as well as other factors such as diabetes, hypertension and smoking with aspirin intolerance for these patients. The secondary outcome was to study the correlation between TNF-alpha as an inflammatory mediator and the prognosis of ischemic stroke for these patients. Our results showed that although smoking and heterozygous A/C of Rs1057910 still have a higher prevalence however statistically insignificant risk for ischemic stroke recurrence compared with other risk factors; OR1.69 and 1.9, 95%CI (0.471–1.695) and (0.321–11.257) respectively. Also, our results suggest that there is a borderline statistically significant correlation between recurrent stroke prognosis and TNF alpha (p = 0.043). Conclusion: This study failed to detect association of Rs1057910 variant of CYP2C9 gene with preventive aspirin for patients with ischemic stroke. However, a somehow significant association was detected between ischemic stroke prognosis and TNF- α as an inflammatory marker. Further research investigations on larger sample size population are encouraged.
- 14 February 2023
- Published by Taylor & Francis in Egyptian Journal of Anaesthesia
- Vol. 39 (1) , 157-166
Open AccessPrecision medicine as a predictive factor for risk of hospitalization of recurrent ischemic stroke patients treated with low dose aspirin. A pilot study
Recurrent ischemic stroke risk after transient ischemic attack was underestimated by most of epidemiological studies due to the widespread use of very different and sometimes restrictive definitions for recurrent stroke instead of a standard definition, making it difficult to assess the benefit of early prevention of recurrence. Knowing that early intervention by treatment with aspirin reduced fatal recurrent stroke and proved to be cost effective by reducing hospital admission, it was worthwhile studying the pharmacogenetics association as well as biological risk factors of aspirin intolerance for patients with recurrent ischemic stroke. Accordingly, our primary outcome was to investigate the association of CYP2C9*3 (Rs1057910) polymorphism as well as other factors such as diabetes, hypertension and smoking with aspirin intolerance for these patients. The secondary outcome was to study the correlation between TNF-alpha as an inflammatory mediator and the prognosis of ischemic stroke for these patients. Our results showed that although smoking and heterozygous A/C of Rs1057910 still have a higher prevalence however statistically insignificant risk for ischemic stroke recurrence compared with other risk factors; OR1.69 and 1.9, 95%CI (0.471–1.695) and (0.321–11.257) respectively. Also, our results suggest that there is a borderline statistically significant correlation between recurrent stroke prognosis and TNF alpha (p = 0.043). Conclusion: This study failed to detect association of Rs1057910 variant of CYP2C9 gene with preventive aspirin for patients with ischemic stroke. However, a somehow significant association was detected between ischemic stroke prognosis and TNF- α as an inflammatory marker. Further research investigations on larger sample size population are encouraged.
- Open Access
- 5 April 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (4) , 523-528
Emerging insights into the relationship between pre-microRNA146a rs2910164 gene polymorphism and TNF-α in ischemic stroke
Objectives: This study investigated the association between the pre-miRNA146a C > G rs2910164 polymorphism and serum TNF-α in Egyptian patients with IS. Methods: A case-control study was conducted on 75 Egyptian cases with IS and 75 sex-matched control subjects aged 57–65 years. Genomic DNA analysis of pre-miRNA146a and TNF-α measurement was performed with real-time PCR and ELISA, respectively. Results: There was a statistically significant difference between cases of ischemic stroke (IS) and control subjects in pre-miRNA146a rs2910164 GG genotype (p=0.017) and G allele (p=0.005). The pre-miRNA146a rs2910164 is significantly associated with large artery atherosclerosis [LAA] in GG genotypes (p=0.019) and G alleles (p=0.004) compared to control subjects. There was a highly statistically significant increase in TNF-α levels (p<0.001) in IS compared to the control group. There was also a statistically significant increase in TNF-α levels (p=0.001) in GG genotypes in IS. Conclusions: Our results showed that there was a statistically significant association between pre-miRNA146a rs2910164 GG genotype and susceptibility to IS and LAA. In addition, there was a statistically significant association between pre-miRNA146a rs2910164 GG genotype and TNF-α in IS subjects.
- 5 April 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (4) , 523-528
Open AccessEmerging insights into the relationship between pre-microRNA146a rs2910164 gene polymorphism and TNF-α in ischemic stroke
Objectives: This study investigated the association between the pre-miRNA146a C > G rs2910164 polymorphism and serum TNF-α in Egyptian patients with IS. Methods: A case-control study was conducted on 75 Egyptian cases with IS and 75 sex-matched control subjects aged 57–65 years. Genomic DNA analysis of pre-miRNA146a and TNF-α measurement was performed with real-time PCR and ELISA, respectively. Results: There was a statistically significant difference between cases of ischemic stroke (IS) and control subjects in pre-miRNA146a rs2910164 GG genotype (p=0.017) and G allele (p=0.005). The pre-miRNA146a rs2910164 is significantly associated with large artery atherosclerosis [LAA] in GG genotypes (p=0.019) and G alleles (p=0.004) compared to control subjects. There was a highly statistically significant increase in TNF-α levels (p<0.001) in IS compared to the control group. There was also a statistically significant increase in TNF-α levels (p=0.001) in GG genotypes in IS. Conclusions: Our results showed that there was a statistically significant association between pre-miRNA146a rs2910164 GG genotype and susceptibility to IS and LAA. In addition, there was a statistically significant association between pre-miRNA146a rs2910164 GG genotype and TNF-α in IS subjects.
- 1 September 2021
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 212, 105922
Vitamin D status in Hashimoto’s thyroiditis and its association with vitamin D receptor genetic variants
- 1 September 2021
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 212, 105922
Vitamin D status in Hashimoto’s thyroiditis and its association with vitamin D receptor genetic variants
- 1 March 2021
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 22 (1) , 52-55
Superiority of rectal snip over serology in detection of schistosomiasis eradication: A pilot study
- 1 March 2021
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 22 (1) , 52-55
Superiority of rectal snip over serology in detection of schistosomiasis eradication: A pilot study